BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 25582248)

  • 41. [A report of two cases of multilocular cystic renal cell carcinoma: review of 51 cases reported and the results of a prognostic survey].
    Tosaka A; Yoshida K; Kobayashi N; Takeuchi S; Uchijima Y; Saitoh H
    Hinyokika Kiyo; 1992 Sep; 38(9):1045-50. PubMed ID: 1414757
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
    Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
    Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Cystic renal cell carcinoma: report of four cases].
    Matsushita Y; Suzuki K; Tamura T; Maeda K; Fujioka T
    Hinyokika Kiyo; 1997 Oct; 43(10):719-22. PubMed ID: 9395907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multilocular cystic renal cell carcinoma: a clinicopathological, immuno- and lectin histochemical study of nine cases.
    Imura J; Ichikawa K; Takeda J; Tomita S; Yamamoto H; Nakazono M; Takimoto T; Ueda Y; Fujimori T
    APMIS; 2004 Mar; 112(3):183-91. PubMed ID: 15153160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Distinct immunophenotypes and prognostic factors in renal cell carcinoma with sarcomatoid differentiation: a systematic study of 19 immunohistochemical markers in 42 cases.
    Yu W; Wang Y; Jiang Y; Zhang W; Li Y
    BMC Cancer; 2017 Apr; 17(1):293. PubMed ID: 28449664
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tubulocystic carcinoma of the kidney: a new entity among renal tumors.
    Azoulay S; Vieillefond A; Paraf F; Pasquier D; Cussenot O; Callard P; Sibony M
    Virchows Arch; 2007 Nov; 451(5):905-9. PubMed ID: 17786473
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
    Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
    Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Clinicopathologic features of primary renal neuroendocrine carcinoma].
    Wang XH; Lu X; He B; Jiang YX; Yu WJ; Wang H; Zhang W; Li YJ
    Zhonghua Bing Li Xue Za Zhi; 2018 Nov; 47(11):851-856. PubMed ID: 30423609
    [No Abstract]   [Full Text] [Related]  

  • 49. [The incidence of malignant transformation of renal cysts of category 1, 2, and 2F by the BOSNIAK classification into multilocular cystic renal cell carcinoma].
    Darenkov SP; Proskokov AA; Agabekian AA; Trofimov IA
    Urologiia; 2018 Jul; (3):111-115. PubMed ID: 30035429
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Multilocular cystic renal cell carcinoma in lower pole moiety of a duplex kidney.
    Liu GM; Ma HS; Li YM
    Int J Surg Pathol; 2012 Dec; 20(6):613-7. PubMed ID: 22456872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cystic MED15::TFE3 translocation renal cell carcinoma: histologic mimicker of multilocular cystic renal neoplasm of low malignant potential with review of the literature.
    Doytcheva K; Gallan AJ; Wang P; Wanjari P; Segal J; Antic T
    Hum Pathol; 2023 Jun; 136():25-33. PubMed ID: 36997032
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multilocular cystic renal cell carcinoma : a report of 45 cases of a kidney tumor of low malignant potential.
    Suzigan S; López-Beltrán A; Montironi R; Drut R; Romero A; Hayashi T; Gentili AL; Fonseca PS; deTorres I; Billis A; Japp LC; Bollito E; Algaba F; Requena-Tapias MJ
    Am J Clin Pathol; 2006 Feb; 125(2):217-22. PubMed ID: 16393684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Role of CD2-associated protein and nephrin expression in multilocular cystic renal cell carcinoma].
    Gong K; Zhao ZX; Lü TJ; Jin J
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):543-7. PubMed ID: 19567077
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mucinous tubular and spindle cell carcinoma of kidney is probably a variant of papillary renal cell carcinoma with spindle cell features.
    Shen SS; Ro JY; Tamboli P; Truong LD; Zhai Q; Jung SJ; Tibbs RG; Ordonez NG; Ayala AG
    Ann Diagn Pathol; 2007 Feb; 11(1):13-21. PubMed ID: 17240302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multilocular cystic renal cell carcinoma: pathological t staging makes no difference to favorable outcomes and should be reclassified. Bhatt JR, Jewett MA, Richard PO, Kawaguchi S, Timilshina N, Evans A, Alibhai S, Finelli A.J Urol. November 2016;196(5):1350-1355.
    Kryvenko ON
    Urol Oncol; 2017 Jun; 35(6):450-451. PubMed ID: 28416104
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tubulocystic renal cell carcinoma: Two-case report and literature review.
    Xing S; Liu A; Yang X; Chen L; Xu D
    Int J Immunopathol Pharmacol; 2021; 35():20587384211002966. PubMed ID: 33726547
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cystic renal cell carcinoma arising from multilocular cystic nephroma of the same kidney.
    Omar AM; Khattak AQ; Lee JA
    Int Braz J Urol; 2006; 32(2):187-9; discussion 189. PubMed ID: 16650296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study.
    Alexiev BA; Drachenberg CB
    Pathol Res Pract; 2014 Apr; 210(4):234-41. PubMed ID: 24485757
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cystic Renal Oncocytoma and Tubulocystic Renal Cell Carcinoma: Morphologic and Immunohistochemical Comparative Study.
    Skenderi F; Ulamec M; Vranic S; Bilalovic N; Peckova K; Rotterova P; Kokoskova B; Trpkov K; Vesela P; Hora M; Kalusova K; Sperga M; Perez Montiel D; Alvarado Cabrero I; Bulimbasic S; Branzovsky J; Michal M; Hes O
    Appl Immunohistochem Mol Morphol; 2016 Feb; 24(2):112-9. PubMed ID: 26180933
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CA9 as a molecular marker for differential diagnosis of cystic renal tumors.
    Li G; Bilal I; Gentil-Perret A; Feng G; Zhao A; Peoc'h M; Genin C; Tostain J; Gigante M
    Urol Oncol; 2012; 30(4):463-8. PubMed ID: 20822935
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.